Skip to search formSkip to main contentSkip to account menu

olodaterol

Known as: 6-hydroxy-8-(1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)-2H-1,4-benzoxazin-3(4H)-one 
National Institutes of Health

Related topics

Related topics

8 relations
28 ACTUAT olodaterol 0.0025 MG/ACTUAT Metered Dose Inhaler [Striverdi]60 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Metered Dose InhalerAdrenergic beta2-Agonists [MoA]olodaterol / tiotropium

Broader (3)

Adrenergic beta-1 Receptor AgonistsBenzoxazinesBronchodilator Agents

Narrower (1)

Olodaterol hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
[Current position of new fixed-dose combination of tiotropium and olodaterol - its role in the treatment of chronic obstructive pulmonary disease in the Czech Republic].
COPD is a serious pulmonary disease with rising global socioeconomic impact. From the perspective of the Czech Republic COPD was… 
2018
2018
Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
2017
2017
Interaction between tiotropium bromide and olodaterol in human bronchial smooth muscle
2016
2016
S34 Effect of 8 and 12 weeks’ once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with copd
T Troosters has received grants from Innovative Medicines Initiative Joint Undertaking and speaker fees from Boehringer Ingelheim… 
2016
2016
Pooled Safety Analysis Of Adjudicated Serious Adverse Events With The Fixed-Dose Combination Of Tiotropium + Olodaterol
Review
2016
Review
2016
Comparative efficacy of umeclidinium/vilanterol versus LABA/LAMA therapies in COPD: A network meta-analysis
Objective: To assess the comparative efficacy of umeclidinium/vilanterol 62.5/25µg OD (UMEC/VI) vs. available LABA/LAMA… 
Review
2015
Review
2015
Tiotropium/olodaterol (Stiolto Respimat) for COPD.
2012
2012
Tiotropium enhances the inhibitory effect of the long acting β2-agonist olodaterol on the release of IL-6 and IL8 by primary human lung fibroblasts of asthma patients
Muscarinic and β2-adrenergic receptors of resident lung cells are modulators of airway inflammation and remodeling. Here, we used… 
2012
2012
Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD
printing supported by . Visit Chiesi at Stand B2.10 MONDAY, SEPTEMBER 3RD 2012 correlated with the production of IL-8. In acute… 
1984
1984
“FDA-approved” indications